Advertisement
Screener

INTELLIA THERAPEUTICS, INC. (NTLA) Cash Flow Breakdown

INTELLIA THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where INTELLIA THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $394.74M went out.
  • Fiscal year ended 2025-12-31: from investing, $228.03M came in.
  • Fiscal year ended 2025-12-31: from financing, $131.49M came in.
  • Fiscal year ended 2025-12-31: change in cash, $35.22M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$394.74M$228.03M$128.18M$3.31M*-$35.22M
2024-12-31-$348.88M$125.57M$176.90M$8.85M*-$37.57M
2023-12-31-$394.09M-$31.35M$119.80M$10.53M*-$295.11M
2022-12-31-$333.29M$160.31M$14.52M$568.44M*$409.98M
2021-12-31-$225.03M-$550.78M$41.09M$695.59M*-$39.12M
2020-12-31-$49.91M-$214.49M$11.57M$360.20M*$107.38M
2019-12-31-$103.24M$25.18M$72.26M$4.18M*-$1.63M
2018-12-31-$61.26M-$260.78M$28.55M$11.67M*-$281.82M
2017-12-31-$65.28M-$10.09M$141.00M$1.98M*$67.61M
2016-12-31$36.11M-$6.17M$170.51M-$3.20M*$197.25M
2015-12-31-$1.76M-$2.55M$70.29M*$65.97M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$83.11M*-$141.57M*$196.12M*
2026-03-31-$117.35M$66.31M$33.57M*-$17.47M
2025-12-31-$69.28M*$27.53M*$625.00K*$1.35M*
2025-09-30-$76.90M*-$741.00K*$97.00K*$114.76M*
2025-06-30-$99.62M*$106.91M*$0.00*$14.65M*
2025-03-31-$148.93M$94.33M$0.00-$54.60M
2024-12-31-$85.19M*$151.56M*$1.03M*$1.29M*
2024-09-30-$84.84M*-$7.71M*$1.70M*$80.50M*
2024-06-30-$58.19M*-$24.19M*$1.18M*$40.07M*
2024-03-31-$120.66M$5.90M$1.96M$58.03M*-$54.77M
2023-12-31-$93.05M*$45.94M*$995.00K*$105.49M*
2023-09-30-$101.38M*$79.50M*$4.38M*$14.72M*
2023-06-30-$90.32M*-$34.54M*$465.00K*$2.05M*
2023-03-31-$109.33M-$122.25M$755.00K$1.47M*-$229.35M
2022-12-31-$89.87M*-$30.15M*$533.00K*$505.23M*
2022-09-30-$78.53M*$47.64M*$722.00K*$23.25M*
2022-06-30-$85.09M*$95.34M*$4.83M*$1.07M*
2022-03-31-$79.80M$47.47M$38.88M$8.44M*$14.99M
2021-12-31-$54.65M*-$159.12M*$1.23M*$1.05M*
2021-09-30-$65.02M*-$399.38M*$20.36M*$648.32M*
2021-06-30-$52.98M*$33.26M*$0.00*$7.13M*
2021-03-31-$52.38M-$25.54M$45.26M$13.34M*-$19.32M
2020-12-31-$40.23M*-$210.92M*$9.61M*$224.49M*
2020-09-30-$28.56M*-$153.98M*$597.00K*
2020-06-30$57.42M*$92.96M*$1.03M*$131.19M*
2020-03-31-$38.55M$57.45M$4.53M$23.77M
2019-12-31-$28.66M*$27.88M*$18.14M*$1.43M*
2019-09-30-$25.45M*-$31.65M*$46.21M*
2019-06-30-$27.68M*$23.25M*$4.27M*$2.20M*
2019-03-31-$21.45M$5.70M$3.64M-$11.76M
2018-12-31-$8.54M*-$256.02M*$1.20M*$28.97M*-$234.39M*
2018-09-30-$12.45M*-$2.02M*$2.18M*-$12.29M*
2018-06-30-$22.50M*-$900.00K*$557.00K*$598.00K*-$22.24M*
2018-03-31-$17.77M-$1.85M$6.72M-$12.90M
2017-12-31-$21.31M*-$2.40M*$648.00K*$141.47M*$118.41M*
2017-09-30-$16.89M*-$2.26M*$371.00K*-$18.78M*
2017-06-30-$15.68M*-$1.27M*$90.00K*-$16.50M*
2017-03-31-$11.40M-$4.16M$47.00K-$15.51M
2016-12-31-$14.41M*-$3.40M*$0.00*-$17.55M*
2016-09-30-$7.61M*-$605.00K*$0.00*-$1.85M*-$10.07M*
2016-06-30$67.55M*-$1.15M*$170.09M*$236.50M*
2016-03-31-$9.42M-$1.01M-$1.20M*-$11.62M
2015-12-31-$5.49M*-$849.00K*-$6.80M*
2015-09-30-$3.27M*-$602.00K*$66.72M*$62.85M*
2015-06-30$2.17M*-$587.00K*$1.29M*
2015-03-31$4.82M-$516.00K$4.33M*$8.63M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
NEOGEN CORP (NEOG)United States$2.979B-247.49
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93